Investors shrug off what appears to be old news about an FDA recall of Vascular Solutions (VASC...


Investors shrug off what appears to be old news about an FDA recall of Vascular Solutions (VASC +5.3%) Guardian II valve, pushing the stock higher after Piper Jaffray initiated the shares with an Overweight rating and an $18 price target. The company had issued its own recall of the valve earlier this month, citing a slightly increased risk of air leakage that may lead to an air embolism, which could result in serious injury or death.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs